Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
Checkpoint blocking therapies are used to treat metastatic melanoma, but can have adverse immune-mediated effects, including liver pathology. Here the authors identify an expanded pool of CD4+ effector memory T cells resulting from prior CMV exposure as a risk factor for this adverse effect in these...
Guardado en:
Autores principales: | James A. Hutchinson, Katharina Kronenberg, Paloma Riquelme, Jürgen J. Wenzel, Gunther Glehr, Hannah-Lou Schilling, Florian Zeman, Katja Evert, Martin Schmiedel, Marion Mickler, Konstantin Drexler, Florian Bitterer, Laura Cordero, Lukas Beyer, Christian Bach, Josef Koestler, Ralph Burkhardt, Hans J. Schlitt, Dirk Hellwig, Jens M. Werner, Rainer Spang, Barbara Schmidt, Edward K. Geissler, Sebastian Haferkamp |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f92b658607e1458c8aa40adb3861c519 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Hannah-Lou Schilling, et al.
Publicado: (2021) -
Microbial Unmasking of Plant Glycosides
por: Kristen A. Biernat, et al.
Publicado: (2018) -
Unmasking chloride attack on the passive film of metals
por: B. Zhang, et al.
Publicado: (2018) -
Dual intestinal parasitosis unmasked by treatment for gastrointestinal sarcoidosis
por: Olutobi Ojuawo, et al.
Publicado: (2021) -
COVID-19 and Health Disparities: Structural Evil Unmasked
por: Philip J. Landrigan, et al.
Publicado: (2021)